Weight loss drug gets US nod to treat sleep apnea; India launch likely next year | India News – Times of India
NEW DELHI: In good news for those suffering from obstructive sleep apnea (OSA), a condition characterised by disordered breathing during sleep, the US FDA has, for the first time, approved an anti-diabetic drug also used for weight loss, sold under the brand name Zepbound (Tirzepatide), to manage the condition in adults with obesity.Treatments currently for…